Fred Alger Management’s Teva Pharmaceuticals TEVA Stock Holding History

Fred Alger Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.91M	Buy	174,322 +92,457	+113%	+$3.08M	0.02%	224
2026 Q1	$2.47M	Sell	81,865 -7,690	-9%	-$247K	0.01%	295
2025 Q4	$2.8M	Buy	89,555 +34,097	+61%	+$840K	0.01%	293
2025 Q3	$1.12M	Sell	55,458 -2,770	-5%	-$48.7K	﹤0.01%	358
2025 Q2	$976K	Buy	+58,228	New	+$940K	﹤0.01%	358
2025 Q1	–	Sell	-139,793	Closed	-$3.08M	–	475
2024 Q4	$3.08M	Sell	139,793 -2,558	-2%	-$46.5K	0.01%	291
2024 Q3	$2.57M	Buy	+142,351	New	+$2.49M	0.01%	307
2016 Q4	–	Sell	-25,970	Closed	-$1.2M	–	522
2016 Q3	$1.2M	Hold	25,970	–	–	0.01%	297
2016 Q2	$1.3M	Sell	25,970 -17,900	-41%	-$953K	0.01%	310
2016 Q1	$2.35M	Sell	43,870 -27,870	-39%	-$1.64M	0.01%	316
2015 Q4	$4.71M	Buy	+71,740	New	+$4.43M	0.02%	258
2015 Q2	–	Sell	-373,469	Closed	-$23.3M	–	537
2015 Q1	$23.3M	Sell	373,469 -1,030,731	-73%	-$59.9M	0.1%	141
2014 Q4	$80.8M	Buy	+1,404,200	New	+$78.2M	0.39%	69

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Fred Alger Management's TEVA Position: Q2 2026 in Review

Fred Alger Management increased its Teva Pharmaceuticals (TEVA) stake by 113% in Q2 2026, buying an estimated $3.08M and bringing the position to 174,322 shares worth $5.91M. The position accounts for 0.02% of the portfolio, ranked #224.

Fred Alger Management first reported a position in TEVA in Q4 2014 and has held it in 13 quarters since. The position peaked at $80.8M in Q4 2014. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Fred Alger Management held 174,322 shares of Teva Pharmaceuticals worth $5.91M as of Q2 2026.
Fred Alger Management bought 92,457 Teva Pharmaceuticals shares in Q2 2026, an estimated $3.08M.
Teva Pharmaceuticals made up 0.02% of Fred Alger Management's portfolio in Q2 2026, its #224 holding.
Fred Alger Management first reported a position in Teva Pharmaceuticals in Q4 2014 and has held it in 13 quarters since.
Fred Alger Management's Teva Pharmaceuticals position peaked at $80.8M in Q4 2014.
673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Fred Alger Management's 13F filing for Q2 2026, filed 14 Aug 2026.